chlordiazepoxide (Q178566)

CHLORDIAZEPOXIDE (English)

chlordiazepoxide tautomer

3 October 2016

tautomer of

0 references

chemical formula

C₁₆H₁₄ClN₃O

1 reference

chlordiazepoxide (English)

16 September 2016

canonical SMILES

CNC1=NC2=CC=C(C=C2C(=[N+](C1)[O-])C3=CC=CC=C3)Cl

1 reference

chlordiazepoxide (English)

19 November 2016

isomeric SMILES

C/N=C\1/CN(C(=C2C=C(C=CC2=N1)Cl)C3=CC=CC=C3)O

1 reference

(2Z)-7-Chloro-2-(methylimino)-5-phenyl-2,3-dihydro-4H-1,4-benzodiazepin-4-ol (English)

16 September 2016

defined daily dose

30 milligram

route of administration

oral administration

1 reference

https://www.whocc.no/atc_ddd_index/?code=N05BA02

50 milligram

route of administration

parenteral route of administration

1 reference

https://www.whocc.no/atc_ddd_index/?code=N05BA02

World Health Organisation international non-proprietary name

chlordiazepoxide (English)

1 reference

chlordiazepoxide (English)

medical condition treated

3 October 2016

1 reference

13 December 2016

1 reference

significant drug interaction

13 December 2016

pethidine

1 reference

A reference set of clinically relevant adverse drug-drug interactions

pethidine

1 reference

A reference set of clinically relevant adverse drug-drug interactions

periciazine

1 reference

A reference set of clinically relevant adverse drug-drug interactions

tramadol

1 reference

A reference set of clinically relevant adverse drug-drug interactions

tramadol

1 reference

A reference set of clinically relevant adverse drug-drug interactions

(RS)-methadone

1 reference

A reference set of clinically relevant adverse drug-drug interactions

(RS)-methadone

1 reference

A reference set of clinically relevant adverse drug-drug interactions

morphine

1 reference

A reference set of clinically relevant adverse drug-drug interactions

morphine

1 reference

A reference set of clinically relevant adverse drug-drug interactions

oxycodone

1 reference

A reference set of clinically relevant adverse drug-drug interactions

oxycodone

1 reference

A reference set of clinically relevant adverse drug-drug interactions

hydromorphone

1 reference

A reference set of clinically relevant adverse drug-drug interactions

hydromorphone

1 reference

A reference set of clinically relevant adverse drug-drug interactions

dihydrocodeine

1 reference

A reference set of clinically relevant adverse drug-drug interactions

dihydrocodeine

1 reference

A reference set of clinically relevant adverse drug-drug interactions

codeine

1 reference

A reference set of clinically relevant adverse drug-drug interactions

codeine

1 reference

A reference set of clinically relevant adverse drug-drug interactions

tapentadol

1 reference

A reference set of clinically relevant adverse drug-drug interactions

tapentadol

1 reference

A reference set of clinically relevant adverse drug-drug interactions

buprenorphine

1 reference

A reference set of clinically relevant adverse drug-drug interactions

mirtazapine

1 reference

A reference set of clinically relevant adverse drug-drug interactions

fentanyl

1 reference

A reference set of clinically relevant adverse drug-drug interactions

alfentanil

1 reference

A reference set of clinically relevant adverse drug-drug interactions

alfentanil

1 reference

A reference set of clinically relevant adverse drug-drug interactions

alfentanil

hypotension

1 reference

A reference set of clinically relevant adverse drug-drug interactions

sufentanil

1 reference

A reference set of clinically relevant adverse drug-drug interactions

sufentanil

hypotension

1 reference

A reference set of clinically relevant adverse drug-drug interactions

(±)-thiopental

1 reference

probably

A reference set of clinically relevant adverse drug-drug interactions

phenobarbital

1 reference

probably

A reference set of clinically relevant adverse drug-drug interactions

primidone

1 reference

probably

A reference set of clinically relevant adverse drug-drug interactions

sodium oxybate

1 reference

A reference set of clinically relevant adverse drug-drug interactions

cognitive disorder

1 reference

A reference set of clinically relevant adverse drug-drug interactions

1 reference

A reference set of clinically relevant adverse drug-drug interactions

hypotension

1 reference

A reference set of clinically relevant adverse drug-drug interactions

sedation

1 reference

A reference set of clinically relevant adverse drug-drug interactions

syncope

1 reference

A reference set of clinically relevant adverse drug-drug interactions

physically interacts with

Thyrotropin releasing hormone receptor

antagonist

1 reference

IUPHAR/BPS Guide to PHARMACOLOGY

Guide to Pharmacology Ligand ID

3370

Gamma-aminobutyric acid type A receptor subunit beta3

17 August 2016

1 reference

14 August 2023

Gamma-aminobutyric acid type A receptor subunit gamma2

1 reference

14 August 2023

Gamma-aminobutyric acid type A receptor subunit alpha3

1 reference

14 August 2023

Gamma-aminobutyric acid type A receptor subunit delta

1 reference

14 August 2023

Gamma-aminobutyric acid type A receptor subunit gamma1

1 reference

14 August 2023

Gamma-aminobutyric acid type A receptor subunit beta1

1 reference

14 August 2023

Gamma-aminobutyric acid type A receptor subunit alpha4

1 reference

14 August 2023

Gamma-aminobutyric acid type A receptor subunit theta

1 reference

14 August 2023

Gamma-aminobutyric acid type A receptor subunit beta2

1 reference

14 August 2023

imported from Wikimedia project

pregnancy category

US pregnancy category D

1 reference

English Wikipedia

LiverTox likelihood score

LiverTox toxicity likelihood category D

1 reference

8 April 2021

https://www.ncbi.nlm.nih.gov/books/n/livertox/Chlordiazepoxide

24 January 2017

0 references

GABAA receptor positive allosteric modulators

1 reference

5 March 2018

hypnotics and sedatives

1 reference

15 March 2018

1 reference

15 March 2018

1 reference

15 March 2018

1 reference

15 March 2018

1 reference

27 February 2018

developmental toxicant

start time

1 January 1992

1 reference

California Proposition 65 list of chemicals

21 February 2020

https://oehha.ca.gov/chemicals/chlordiazepoxide

chlordiazePOXIDE

Institute for Safe Medication Practices

1 reference

https://www.ismp.org/recommendations/tall-man-letters-list

InChI=1S/C16H14ClN3O/c1-18-15-10-20(21)16(11-5-3-2-4-6-11)13-9-12(17)7-8-14(13)19-15/h2-9,21H,10H2,1H3/b18-15-

2 September 2022

MCN code

2933.91.15

0 references

Commons category

Chlordiazepoxide

0 references

Identifiers

InChI

1 reference

based on heuristic

inferred from SMILES

2 references

chlordiazepoxide (English)

19 November 2016

ChEBI release 2020-09-01

CAS Registry Number

58-25-3

2 references

https://commonchemistry.cas.org/detail?cas_rn=58-25-3

chlordiazepoxide (English)

19 November 2016

5 April 2021

1 reference

Chlordiazepoxide (English)

19 November 2016

1 reference

chlordiazepoxide (English)

16 September 2016

Reaxys registry number

550356

1 reference

chlordiazepoxide (English)

3 October 2016

ChEBI ID

3611

mapping relation type

1 reference

CHLORDIAZEPOXIDE (English)

19 November 2016

1 reference

CHLORDIAZEPOXIDE (English)

19 November 2016

2 references

inferred from InChIKey

MSBNK-Athens_Univ-AU154206

1 reference

MassBank accession ID

0 references

MSBNK-Fac_Eng_Univ_Tokyo-JP003160

0 references

MSBNK-Fac_Eng_Univ_Tokyo-JP003835

0 references

MSBNK-Waters-WA001504

0 references

MSBNK-Waters-WA001505

0 references

MSBNK-Waters-WA001506

0 references

MSBNK-Waters-WA001507

0 references

MSBNK-Waters-WA001508

0 references

MSBNK-Waters-WA001509

0 references

SPLASH

splash10-0udi-0079000000-a3045f81d776a5127fe9

0 references

splash10-001i-5590000000-a20477457b7e9f8a22ea

0 references

HSDB ID

3028

1 reference

Hazardous Substances Data Bank

28 October 2019

CHLORDIAZEPOXIDE (English)

10 May 2021

2 references

Mapping file of InChIStrings, InChIKeys and DTXSIDs for the EPA CompTox Dashboard

DSSTOX compound identifier

0 references

0 references

1 reference

chlordiazepoxide (English)

ECHA Substance Infocard ID

19 November 2016

100.000.337

1 reference

ECHA Substance Infocard database

ECHA Substance Infocard ID

100.000.337

27 December 2018

Chlordiazepoxide (English)

quotation

CAS no.: 58-25-3 (English)

1 reference

Guide to Pharmacology Ligand ID

Chlordiazepoxide (English)

publication date

17 November 2015

3370

1 reference

IUPHAR/BPS Guide to PHARMACOLOGY

Guide to Pharmacology Ligand ID

3370

chlordiazepoxide (English)

19 November 2016

Chlordiazepoxide

0 references

MeSH tree code

D03.633.100.079.080.150

0 references

RxNorm ID

2356

1 reference

chlordiazepoxide (English)

19 November 2016

DrugBank ID

DB00475

1 reference

Human Metabolome Database ID

HMDB0014618

2 references

based on heuristic

inferred from InChIKey

2 references

chlordiazepoxide (English)

19 November 2016

MedlinePlus drug identifier

a682078

0 references

PatientsLikeMe treatment ID

0 references

1 reference

chlordiazepoxide (English)

19 November 2016

0 references

1 reference

California Proposition 65 list of chemicals

chlordiazepoxide (English)

3 October 2016

1 reference

2 December 2019

https://oehha.ca.gov/chemicals/chlordiazepoxide

DeCS ID

2752

0 references

Encyclopædia Britannica Online ID

science/chlordiazepoxide

subject named as

chlordiazepoxide

0 references

1 reference

28 October 2013

1 reference

9 July 2020

Microsoft Academic ID

0 references

0 references

1 reference

26 January 2022

https://docs.openalex.org/download-snapshot/snapshot-data-format

UK Parliament thesaurus ID

515650

subject named as

Chlordiazepoxide

0 references

UMLS CUI

C0008188

1 reference

chlordiazepoxide (English)

19 November 2016

0 references

0 references

WordNet 3.1 Synset ID

03025724-n

1 reference